Home   >  
Angiogenesis/Protein Tyrosine Kinase
  >  
VEGFR

Classified by application

All Products

Signaling Pathways

Research Areas

Nature products

Antibodies

Peptides

Catalysts

Impurities

Intermediate

Raw Materials

VEGFR

Chemical Structure Cat. No. Product Name CAS No.
SU 5205 Chemical Structure
BCP25520 SU 5205 3476-86-6
SU 5205 is a VEGFR2 inhibitor.
Vandetanib trifluoroacetate Chemical Structure
BCP33121 Vandetanib trifluoroacetate 338992-53-3
Vandetanib trifluoroacetate is a potent inhibitor of VEGFR2 with IC50 of 40 nM.
PTC299 Chemical Structure
BCP32869 PTC299 1256565-36-2
PTC299 is a potent, orally bioavailable VEGFA inhibitor, targets dihydroorotate dehydrogenase (DHODH), resulting in cell growth inhibition and differentiation in leukemias, including acute myeloid leukemia, linking DHODH regulation and stress-induced VEGFA and angiogenesis.
hVEGF-IN-1 Chemical Structure
BCP32794 hVEGF-IN-1 1637443-98-1
hVEGF-IN-1 represses human VEGF-A translation and shows antitumor activity.
JK-P3 Chemical Structure
BCP32785 JK-P3 942655-44-9
JK-P3 is a VEGFR2 inhibitor with IC50 values of 7.8 μM.
AG1406 Chemical Structure
BCP32621 AG1406 71308-34-4
AG1406 is a selective inhibitor of the receptor tyrosine kinase VEGF receptor 2 .
Ramucirumab Chemical Structure
BCP26258 Ramucirumab 947687-13-0
Ramucirumab is a human VEGFR-2 antagonist for the treatment of solid tumors. Ramucirumab is a recombinant human immunoglobulin G1 monoclonal antibody that binds to the extracellular binding domain of VEGFR-2 and prevents the binding of VEGFR ligands: VEGF-A, VEGF-C, and VEGF-D.
MAZ51 Chemical Structure
BCP31595 MAZ51 163655-37-6
MAZ51 is an indolinone that selectively antagonizes the activation of VEGFR3 by VEGFC (IC50 = 1 μM) without blocking VEGFC-mediated stimulation of VEGFR2.
JNJ-38158471 Chemical Structure
BCP21621 JNJ-38158471 951151-97-6
JNJ-38158471 is a well tolerated, orally available, highly selective VEGFR-2 inhibitor with IC50=40nM.
TG 100572 Hydrochloride Chemical Structure
BCP21364 TG 100572 Hydrochloride 867331-64-4
TG 100572 Hydrochloride is a multi-targeted kinase inhibitor which inhibits receptor tyrosine kinases and Src kinases; has IC50s of 2, 7, 2, 16, 13, 5, 0.5, 6, 0.1, 0.4, 1, 0.2 nM for VEGFR1, VEGFR2, FGFR1, FGFR2, PDGFRβ, Fgr, Fyn, Hck, Lck, Lyn, Src, Yes, respectively.
123下一页末页共 124 条记录 1 / 13 页 
0086-13720134139